Table of Contents

Part One : Core methods
CHAPTER 1
Starting a review (Pages: 1-12)
  • Toby J Lasserson
  • James Thomas
  • Julian PT Higgins
CHAPTER 2
Determining the scope of the review and the questions it will address (Pages: 13-31)
  • James Thomas
  • Dylan Kneale
  • Joanne E McKenzie
  • Sue E Brennan
  • Soumyadeep Bhaumik
CHAPTER 3
Defining the criteria for including studies and how they will be grouped for the synthesis (Pages: 33-65)
  • Joanne E McKenzie
  • Sue E Brennan
  • Rebecca E Ryan
  • Hilary J Thomson
  • Renea V Johnston
  • James Thomas
CHAPTER 4
Searching for and selecting studies (Pages: 67-107)
  • Carol Lefebvre
  • Julie Glanville
  • Simon Briscoe
  • Anne Littlewood
  • Chris Marshall
  • Maria‐Inti Metzendorf
  • Anna Noel‐Storr
  • Tamara Rader
  • Farhad Shokraneh
  • James Thomas
  • L. Susan Wieland
  • on behalf of the Cochrane Information Retrieval Methods Group
CHAPTER 5
Collecting data (Pages: 109-141)
  • Tianjing Li
  • Julian PT Higgins
  • Jonathan J Deeks
CHAPTER 7
Considering bias and conflicts of interest among the included studies (Pages: 177-204)
  • Isabelle Boutron
  • Matthew J Page
  • Julian PT Higgins
  • Douglas G Altman
  • Andreas Lundh
  • Asbjørn Hróbjartsson
  • on behalf of the Cochrane Bias Methods Group
CHAPTER 8
Assessing risk of bias in a randomized trial (Pages: 205-228)
  • Julian PT Higgins
  • Jelena Savović
  • Matthew J Page
  • Roy G Elbers
  • Jonathan AC Sterne
CHAPTER 9
Summarizing study characteristics and preparing for synthesis (Pages: 229-240)
  • Joanne E McKenzie
  • Sue E Brennan
  • Rebecca E Ryan
  • Hilary J Thomson
  • Renea V Johnston
CHAPTER 10
Analysing data and undertaking meta‐analyses (Pages: 241-284)
  • Jonathan J Deeks
  • Julian PT Higgins
  • Douglas G Altman
  • on behalf of the Cochrane Statistical Methods Group
CHAPTER 11
Undertaking network meta‐analyses (Pages: 285-320)
  • Anna Chaimani
  • Deborah M Caldwell
  • Tianjing Li
  • Julian PT Higgins
  • Georgia Salanti
CHAPTER 14
Completing ‘Summary of findings’ tables and grading the certainty of the evidence (Pages: 375-402)
  • Holger J Schünemann
  • Julian PT Higgins
  • Gunn E Vist
  • Paul Glasziou
  • Elie A Akl
  • Nicole Skoetz
  • Gordon H Guyatt
  • on behalf of the Cochrane GRADEing Methods Group (formerly Applicability and Recommendations Methods Group) and the Cochrane Statistical Methods Group
CHAPTER 15
Interpreting results and drawing conclusions (Pages: 403-431)
  • Holger J Schünemann
  • Gunn E Vist
  • Julian PT Higgins
  • Nancy Santesso
  • Jonathan J Deeks
  • Paul Glasziou
  • Elie A Akl
  • Gordon H Guyatt
  • on behalf of the Cochrane GRADEing Methods Group
Part Two : Specific perspectives in reviews
CHAPTER 16
Equity and specific populations (Pages: 433-449)
  • Vivian A Welch
  • Jennifer Petkovic
  • Janet Jull
  • Lisa Hartling
  • Terry Klassen
  • Elizabeth Kristjansson
  • Jordi Pardo Pardo
  • Mark Petticrew
  • David J Stott
  • Denise Thomson
  • Erin Ueffing
  • Katrina Williams
  • Camilla Young
  • Peter Tugwell
CHAPTER 17
Intervention complexity (Pages: 451-477)
  • James Thomas
  • Mark Petticrew
  • Jane Noyes
  • Jacqueline Chandler
  • Eva Rehfuess
  • Peter Tugwell
  • Vivian A Welch
CHAPTER 18
Patient‐reported outcomes (Pages: 479-492)
  • Bradley C Johnston
  • Donald L Patrick
  • Tahira Devji
  • Lara J Maxwell
  • Clifton O Bingham III
  • Dorcas E Beaton
  • Maarten Boers
  • Matthias Briel
  • Jason W Busse
  • Alonso Carrasco‐Labra
  • Robin Christensen
  • Bruno R da Costa
  • Regina El Dib
  • Anne Lyddiatt
  • Raymond W Ostelo
  • Beverley Shea
  • Jasvinder Singh
  • Caroline B Terwee
  • Paula R Williamson
  • Joel J Gagnier
  • Peter Tugwell
  • Gordon H Guyatt
CHAPTER 19
Adverse effects (Pages: 493-505)
  • Guy Peryer
  • Su Golder
  • Daniela R Junqueira
  • Sunita Vohra
  • Yoon Kong Loke
  • on behalf of the Cochrane Adverse Effects Methods Group
CHAPTER 20
Economic evidence (Pages: 507-523)
  • Ian Shemilt
  • Patricia Aluko
  • Erin Graybill
  • Dawn Craig
  • Catherine Henderson
  • Michael Drummond
  • Edward CF Wilson
  • Shannon Robalino
  • Luke Vale
  • on behalf of the Campbell and Cochrane Economics Methods Group
CHAPTER 21
Qualitative evidence (Pages: 525-545)
  • Jane Noyes
  • Andrew Booth
  • Margaret Cargo
  • Kate Flemming
  • Angela Harden
  • Janet Harris
  • Ruth Garside
  • Karin Hannes
  • Tomás Pantoja
  • James Thomas
Part Three : Further topics
CHAPTER 22
Prospective approaches to accumulating evidence (Pages: 547-568)
  • James Thomas
  • Lisa M Askie
  • Jesse A Berlin
  • Julian H Elliott
  • Davina Ghersi
  • Mark Simmonds
  • Yemisi Takwoingi
  • Jayne F Tierney
  • Julian PT Higgins
CHAPTER 23
Including variants on randomized trials (Pages: 569-593)
  • Julian PT Higgins
  • Sandra Eldridge
  • Tianjing Li
CHAPTER 24
Including non‐randomized studies on intervention effects (Pages: 595-620)
  • Barnaby C Reeves
  • Jonathan J Deeks
  • Julian PT Higgins
  • Beverley Shea
  • Peter Tugwell
  • George A Wells
  • on behalf of the Cochrane Non‐Randomized Studies of Interventions Methods Group
CHAPTER 25
Assessing risk of bias in a non‐randomized study (Pages: 621-641)
  • Jonathan AC Sterne
  • Miguel A Hernán
  • Alexandra McAleenan
  • Barnaby C Reeves
  • Julian PT Higgins
CHAPTER 26
Individual participant data (Pages: 643-658)
  • Jayne F Tierney
  • Lesley A Stewart
  • Mike Clarke
  • on behalf of the Cochrane Individual Participant Data Meta‐analysis Methods Group